Cardiovascular Adverse Events and Comorbidity Considerations Disease in Men with Non-Metastatic Prostate Cancer – Christopher Wallis & Zachary Klaassen

Prostate cancer and cardiovascular (CV) disease share several risk factors, with the incidence of both rising with increasing age. Systemic prostate cancer therapies may increase CV risk. In this UroToday Journal Club, Christopher Wallis and Zachary Klaassen highlight a recent paper published in Urologic Oncology: Seminars and Original Investigations titled ” Androgen receptor inhibitor…

Read the full article here

Related Articles